9.07

0.78% 0.07

After Hours: 9.09 0.02 +0.22%

Adicet Bio Inc (ACET)

Overview News Price History Option Chain Financials Discussions Forecast

Adicet Bio Inc stock is traded at $9.07, with a volume of 64,302. It is up +0.78% in the last 24 hours and up +24.93% over the past month. Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. It is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. The company's main product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, and is being developed for the potential treatment of autoimmune diseases. Additionally, it is pursuing ADI-212, a next-generation gene-edited and armored clinical candidate designed to target prostate-specific membrane antigen (PSMA).

Previous Close:

$9.00

Open:

$9.1

24h Volume:

64,302

Relative Volume:

0.57

Market Cap:

$84.79M

Revenue:

$24.99M

Net Income/Loss:

$-108.83M

P/E Ratio:

-0.6035

EPS:

-15.0286

Net Cash Flow:

$-91.62M

1W Performance:

+5.96%

1M Performance:

+24.93%

6M Performance:

+12.67%

1Y Performance:

-6.61%

1-Day Range:

$9.055

$9.42

1-Week Range:

$8.40

$9.42

52-Week Range:

$6.01

$17.44

Adicet Bio Inc Stock (ACET) Company Profile

Name

Adicet Bio Inc

Sector

Healthcare (1100)

Industry

Biotechnology (615)

Phone

617-482-2333

Address

131 DARTMOUTH STREET, BOSTON

Employee

102

Twitter

Next Earnings Date

2026-08-06

Latest SEC Filings

ACET's Discussions on Twitter

Compare ACET vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ACET Adicet Bio Inc	9.07	80.77M	24.99M	-108.83M	-91.62M	-15.03
VRTX Vertex Pharmaceuticals Inc	529.59	126.07B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	649.81	65.37B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	916.80	57.70B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	313.04	40.19B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	189.99	39.82B	742.00K	-1.37B	-1.07B	-7.0731

Adicet Bio Inc Stock (ACET) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-30-24	Resumed	Guggenheim	Buy
Sep-11-24	Downgrade	H.C. Wainwright	Buy → Neutral
Jun-27-23	Downgrade	Guggenheim	Buy → Neutral
Jun-27-23	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Jun-01-23	Downgrade	JP Morgan	Overweight → Neutral
Sep-21-22	Initiated	JP Morgan	Overweight
Mar-31-22	Initiated	SMBC Nikko	Outperform
Mar-08-22	Initiated	Truist	Buy
Mar-04-22	Initiated	Jefferies	Buy
May-18-21	Initiated	BTIG Research	Buy
Apr-23-21	Initiated	H.C. Wainwright	Buy
Apr-14-21	Initiated	Canaccord Genuity	Buy
Apr-08-21	Initiated	Guggenheim	Buy
Nov-04-20	Initiated	B. Riley Securities	Buy
Oct-27-20	Initiated	JMP Securities	Mkt Outperform
Oct-16-20	Initiated	Wedbush	Outperform

View All

Adicet Bio Inc Stock (ACET) Latest News

Jul 01, 2026

Is Adicet Bio (ACET) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Jul 01, 2026

Jun 29, 2026

Adicet Bio, Inc.(NasdaqCM: ACET) added to Russell Microcap Value Benchmark Index - marketscreener.com

Jun 29, 2026

Adicet Bio, Inc.(NasdaqCM: ACET) added to Russell Microcap Index - marketscreener.com

Jun 29, 2026

Jun 28, 2026

Adicet Bio, Inc.(NasdaqCM: ACET) added to Russell 3000E Value Benchmark - marketscreener.com

Jun 28, 2026

Jun 26, 2026

Adicet Bio (ACET) CEO Chen Schor receives 55,000 stock options at $8.10 - Stock Titan

Jun 23, 2026

Adicet Bio (ACET) grants CSO Blake Aftab 55,000 stock options - Stock Titan

Jun 23, 2026

Director at Adicet Bio (NASDAQ: ACET) receives 4,200 stock options grant - Stock Titan

Jun 23, 2026

Director at Adicet Bio (ACET) awarded 4,200 options at $8.10 strike - Stock Titan

Jun 23, 2026

Adicet Bio (ACET) director receives stock options for 4,200 shares at $8.10 - Stock Titan

Jun 23, 2026

Adicet Bio (ACET) director receives 4,200 stock options at $8.10 strike - Stock Titan

Jun 23, 2026

Director Katie Peng receives 4,200 Adicet Bio (ACET) stock options at $8.10 - Stock Titan

Jun 23, 2026

Director at Adicet Bio (ACET) receives 4,200 stock options award - Stock Titan

Jun 23, 2026

ACET Q1 2026 Earnings: EPS Beats Estimates by 40.7% as Clinical Progress ContinuesEBITDA Analysis - dars.gov.et

Jun 23, 2026

Jun 18, 2026

Adicet Bio Stockholders Back Directors, Pay and Auditor - TipRanks

Jun 18, 2026

Adicet Bio (ACET) investors back board nominees, pay and KPMG at 2026 meeting - Stock Titan

Jun 18, 2026